Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Aerosolized amphotericin B-liposomes for treatment of systemic Candida infections in mice.

Gilbert BE, Wyde PR, Lopez-Berestein G, Wilson SZ.

Antimicrob Agents Chemother. 1994 Feb;38(2):356-9.

2.

Characterization and administration of cyclosporine liposomes as a small-particle aerosol.

Gilbert BE, Wilson SZ, Garcon NM, Wyde PR, Knight V.

Transplantation. 1993 Oct;56(4):974-7.

PMID:
8212222
3.
4.
5.
7.

Safety and pharmacokinetics of rimantadine small-particle aerosol.

Atmar RL, Greenberg SB, Quarles JM, Wilson SZ, Tyler B, Feldman S, Couch RB.

Antimicrob Agents Chemother. 1990 Nov;34(11):2228-33.

8.

High-dose, short-duration ribavirin aerosol therapy in children with suspected respiratory syncytial virus infection.

Englund JA, Piedra PA, Jefferson LS, Wilson SZ, Taber LH, Gilbert BE.

J Pediatr. 1990 Aug;117(2 Pt 1):313-20.

PMID:
2380833
9.

Small particle aerosols of enviroxime-containing liposomes.

Gilbert BE, Six HR, Wilson SZ, Wyde PR, Knight V.

Antiviral Res. 1988 Sep;9(6):355-65.

PMID:
3228281
10.

Activity against rhinoviruses, toxicity, and delivery in aerosol of enviroxime in liposomes.

Wyde PR, Six HR, Wilson SZ, Gilbert BE, Knight V.

Antimicrob Agents Chemother. 1988 Jun;32(6):890-5.

12.
13.

Protection of mice from lethal influenza virus infection with high dose-short duration ribavirin aerosol.

Wyde PR, Wilson SZ, Gilbert BE, Smith RH.

Antimicrob Agents Chemother. 1986 Dec;30(6):942-4.

14.

Limited efficacy of aerosolized recombinant alpha interferon against virulent influenza A/HK infection in mice.

Sun CS, Wilson SZ, Wyde PR.

Proc Soc Exp Biol Med. 1986 Feb;181(2):298-304.

PMID:
3945639
15.

Ribavirin small-particle aerosol treatment of infections caused by influenza virus strains A/Victoria/7/83 (H1N1) and B/Texas/1/84.

Gilbert BE, Wilson SZ, Knight V, Couch RB, Quarles JM, Dure L, Hayes N, Willis G.

Antimicrob Agents Chemother. 1985 Mar;27(3):309-13.

16.

Duration of effect of interferon aerosol prophylaxis of vesicular stomatitis virus infection in mice.

Wyde PR, Sun CS, Wilson SZ, Knight V.

Antimicrob Agents Chemother. 1985 Jan;27(1):60-4.

17.

Interferon aerosol suppression of vesicular stomatitis virus replication in the lungs of infected mice.

Wyde PR, Wilson SZ, Sun CS, Knight V.

Antimicrob Agents Chemother. 1984 Oct;26(4):450-4.

18.

Treatment of influenza A (H1N1) virus infection with ribavirin aerosol.

Wilson SZ, Gilbert BE, Quarles JM, Knight V, McClung HW, Moore RV, Couch RB.

Antimicrob Agents Chemother. 1984 Aug;26(2):200-3.

19.

Pulmonary deposition and clearance of aerosolized interferon.

Wyde PR, Wilson SZ, Kramer MJ, Sun CS, Knight V.

Antimicrob Agents Chemother. 1984 Jun;25(6):729-34.

20.

Efficacy of aerosolized recombinant interferons against vesicular stomatitis virus-induced lung infection in cotton rats.

Sun CS, Wyde PR, Wilson SZ, Knight V.

J Interferon Res. 1984 Fall;4(4):449-59.

PMID:
6094681
21.

Ribavirin aerosol treatment of bronchiolitis associated with respiratory syncytial virus infection in infants.

Taber LH, Knight V, Gilbert BE, McClung HW, Wilson SZ, Norton HJ, Thurson JM, Gordon WH, Atmar RL, Schlaudt WR.

Pediatrics. 1983 Nov;72(5):613-8.

PMID:
6356005
22.

Ribavirin aerosol treatment of influenza B virus infection.

McClung HW, Knight V, Gilbert BE, Wilson SZ, Quarles JM, Divine GW.

JAMA. 1983 May 20;249(19):2671-4.

PMID:
6341642
23.

Cell-mediated cytotoxic responses in lungs of cotton rats infected with respiratory syncytial virus.

Sun CS, Wyde PR, Wilson SZ, Knight V.

Am Rev Respir Dis. 1983 Apr;127(4):460-4.

PMID:
6340570
25.

Ribavirin aerosol treatment of influenza B virus infection.

McClung HW, Knight V, Gilbert BE, Wilson SZ, Quarles JM, Couch RB, Divine GW, Gordon WH, Thurston JM, Atmar RL, et al.

Trans Assoc Am Physicians. 1983;96:284-93.

PMID:
6093312
26.

Prophylactic effect of low doses of human leukocyte interferon against infection with rhinovirus.

Greenberg SB, Harmon MW, Couch RB, Johnson PE, Wilson SZ, Dacso CC, Bloom K, Quarles J.

J Infect Dis. 1982 Apr;145(4):542-6.

PMID:
6175705
27.

[Combined action of remantadine (amantadine) and ribavirin on experimental influenza].

Galegov GA, Knight V, Pushkarskaia NL, Wilson SZ, Couch RB.

Vopr Virusol. 1981 Nov-Dec;(6):697-701. Russian.

PMID:
7347232
28.

Ribavirin small-particle aerosol treatment of influenza.

Knight V, McClung HW, Wilson SZ, Waters BK, Quarles JM, Cameron RW, Greggs SE, Zerwas JM, Couch RB.

Lancet. 1981 Oct 31;2(8253):945-9.

PMID:
6117726
29.

Lack of interference of guanosine with ribavirin aerosol treatment of influenza A infection in mice.

Knight V, Wilson SZ, Alling DW, Moore RV, Longoria RM.

Antimicrob Agents Chemother. 1981 Oct;20(4):477-80.

30.

Amantadine and ribavirin aerosol treatment of influenza A and B infection in mice.

Wilson SZ, Knight V, Wyde PR, Drake S, Couch RB.

Antimicrob Agents Chemother. 1980 Apr;17(4):642-8.

31.

Serial studies of leukocyte chemiluminescence: lack of effect of macrolide antibiotic therapy.

Martin RR, Putman M, Greenberg SB, Wallace RJ Jr, Wilson SZ.

J Med. 1980;11(1):39-48.

PMID:
6995547
32.

Amantadine aerosol in humans.

Knight V, Bloom K, Wilson SZ, Wilson RK.

Antimicrob Agents Chemother. 1979 Nov;16(5):572-8.

33.

Amantadine small-particle aerosol: generation and delivery to man.

Wilson SZ, Knight V, Moore R, Larson EW.

Proc Soc Exp Biol Med. 1979 Jul;161(3):350-4. No abstract available.

PMID:
461462
34.

Quantitative nasal cultures from carriers of Staphylococcus aureus: effects of oral therapy with erythromycin, rosamicin, and placebo.

Wilson SZ, Martin RR, Putman M, Greenberg SB, Wallace RJ Jr, Jemsek JG.

Antimicrob Agents Chemother. 1979 Mar;15(3):379-83.

35.

In vivo effects of josamycin, erythromycin, and placebo therapy on nasal carriage of Staphylococcus aureus.

Wilson SZ, Martin RR, Putman M.

Antimicrob Agents Chemother. 1977 Mar;11(3):407-10.

Supplemental Content

Loading ...
Support Center